Riskpilot← Back to searchSign inGet full accessNovicur Pharma AB
ABActiveOrg 5594085523Önsvala Allé 15Manufacture of pharmaceutical preparations · NACE 2120Est. 202220-49 employees
Revenue 2024
SEK 31,7M
+136% vs 2023
EBITDA margin
8.8%
+151% vs 2023
Equity ratio
5.2%
Financial strength
Net profit 2024
SEK 1,9M
+272% vs 2023
| Revenue | SEK 31,7M | +136% |
| EBITDA | SEK 2,8M | +151% |
| Net profit | SEK 1,9M | +272% |
| Total assets | SEK 45,5M | +359% |
| Equity | SEK 2,4M | +355% |
| Employees | — | — |
Legal name
Novicur Pharma AB
Org number
5594085523
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
28 november 2022
Share capital
SEK 25 000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget utvecklar, producerar, importerar och marknadsför läkemedel samt bedriver därmed förenlig verksamhet.
Address
Önsvala Allé 15
Email
erik.strandberg@medovia.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 13 430 | 31 700 |
| Staff expenses | — | — |
| EBITDA | −5 465 | 2 796 |
| Depreciation & amort. | −250 | −337 |
| EBIT | −5 715 | 2 459 |
| Net financials | −99 | −852 |
| Profit before tax | 636 | 2 327 |
| Tax | −138 | −472 |
| Net profit | 498 | 1 855 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 9 915 | 45 491 |
| Equity | 523 | 2 378 |
| Long-term debt | 0 | 10 800 |
| Short-term debt | 9 172 | 31 313 |
| Total debt | 9 172 | 42 113 |
EBITDA margin
8.8%
This company
15.8%
Market median
-44% vs market
20232024
Equity ratio
5.2%
This company
38.2%
Market median
-86% vs market
20232024
Return on equity
78.0%
This company
18.4%
Market median
+324% vs market
20232024
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
20232024
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20232024
Debt / equity
18.13×
This company
0.62×
Market median
-2824% vs market
20232024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OJ Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Medovia AB | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medovia AB
Novicur Pharma AB Board members of Novicur Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olof Johannes Nordgaard | Chief Auditor | 0 companies |
| Jan Anders Fredrik Lovén | Deputy Board Member | 0 companies |
| Jan Totte Dahlin | Deputy Board Member | 0 companies |
| Viktor Elias Bergman Gullmark | Deputy Board Member | 0 companies |
| Andreas Hans Eddie Ottosson | Deputy Board Member | 0 companies |
| John Patrick Berlips | Board of Directors | 0 companies |
| Anna Matilda Sjödin | Deputy Board Member | 0 companies |
| Anna Camilla Biström | Deputy Board Member | 0 companies |
| Jens-Leo Hubertus Berlips | Deputy Board Member | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Linn Mikaela Engman | Deputy Board Member | 0 companies |
| Emelie Sofia Bergh | Deputy Board Member | 0 companies |
| Anna Carolina Maria Bjarnhagen | Deputy Board Member | 0 companies |
| Lars Jonas Högdahl | Deputy Board Member | 0 companies |
| Elin Anna Margareta Spjut | Deputy Board Member | 0 companies |
| Eva Evelina Evelyn Sjöstedt | Deputy Board Member | 0 companies |
| Mari Sinikka Kovaniemi Feldt | Deputy Board Member | 0 companies |
| Olina Kristina Maria Wåhlstedt | Deputy Board Member | 0 companies |
| Peter Olof Elmquist | Board of Directors | 0 companies |
| Anna Klara Alina Bruksås Nybjörk | Deputy Board Member | 0 companies |